Paclitaxel plus Eftilagimod Alpha, a soluble LAG-3 protein, in metastatic, HR+ breast cancer: results from AIPAC, a randomized, placebo controlled phase IIb trial
by Wildiers, Hans (Author)
, Armstrong, Anne (Author)
, Cuypere, Eveline (Author)
, Dalenc, Florence (Author)
, Dirix, Luc (Author)
, Chan, Steve (Author)
, Marmé, Frederik (Author)
, Schröder, Carolina P. (Author)
, Huober, Jens (Author)
, Duhoux, Francois P. (Author)
, Vuylsteke, Peter (Author)
, Jager, Agnes (Author)
, Brain, Etienne (Author)
, Kuemmel, Sherko (Author)
, Pápai, Zsuzsanna (Author)
, Menke-van der Houven van Oordt, Catharina Willemien (Author)
, Perjesi, Luca (Author)
, Mueller, Christian (Author)
, Brignone, Chrystelle (Author)
, Triebel, Frederic (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource